NewStem Announces $4 million Seed Investment

Press Release – July 16, 2018

JERUSALEM, July 16, 2018 /PRNewswire/ — NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy’s effectiveness, today announced a $4 million seed financing from a publicly-traded US-based company to be named NovelStem International Corp. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University.